Trial intelligence / Profile preview

Effectiveness of bupivacaine on pain relief after unilateral knee arthroplasty

IRCT20220731055587N1Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Aug 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of bupivacaine in postoperative pain, sponsored by Mashhad University of Medical Sciences. Started Aug 2022; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on IRCT20220731055587N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220731055587N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call